Skip to main content
$3.35 -$0.09 (-2.6%)

10:32 AM EDT on 09/24/20

Cytodyn Inc Com (NASDAQOTH:CYDY)

CAPS Rating: 1 out of 5

Current Price $3.35 Mkt Cap $2.0B
Open $3.43 P/E Ratio 0.00
Prev. Close $3.43 Div. (Yield) $0.00 (0.0%)
Daily Range $3.35 - $3.43 Volume 239,650
52-Wk Range $0.26 - $10.01 Avg. Daily Vol. 5,152,380

Caps

How do you think NASDAQOTH:CYDY will perform against the market?

Add Stock to CAPS Watchlist

All Players

15 Outperform
26 Underperform
 

All-Star Players

3 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTH:CYDY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Knickerbocker26 (< 20)
Submitted August 13, 2020

Recent safety and efficacy trial results are very favorable. No large media outlets have picked up on this. Huge amount of coordinated short activity depressing price. Uplisting to Nasdaq imminent.

jed71 (98.88)
Submitted June 24, 2014

I know what you’re thinking. Another biotech company? Yeah, you’re right, it’s probably not a good idea for me to be picking on this firm. My normal warning : I suck at selecting biotech’s. Please read about this one on your own before selecting your… More

NASDAQOTH:CYDY VS S&P 500 (SPY)

NASDAQOTH:CYDY Summary

Fools bullish on NASDAQOTH:CYDY are also bullish on:

Fools bearish on NASDAQOTH:CYDY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYDY.

Recs

0
Member Avatar ramosmf71 (49.80) Submitted: 9/8/2020 3:51:26 PM : Outperform Start Price: $4.93 NASDAQ OTHER:CYDY Score: -27.01

COVID 19 results are great, has 30 indications for treatment

Recs

1
Member Avatar Knickerbocker26 (< 20) Submitted: 8/13/2020 7:24:44 PM : Outperform Start Price: $4.64 NASDAQ OTHER:CYDY Score: -21.88

Recent safety and efficacy trial results are very favorable. No large media outlets have picked up on this. Huge amount of coordinated short activity depressing price. Uplisting to Nasdaq imminent.

Recs

0
Member Avatar BMcDH (< 20) Submitted: 7/27/2020 8:45:51 AM : Outperform Start Price: $5.69 NASDAQ OTHER:CYDY Score: -39.97

Lerronlimab as cancer immunotherapy, broad spectrum antiviral, and comprehensive treatment for cytokine storm in infection

Leaderboard

Find the members with the highest scoring picks in CYDY.

Score Leader

quinpeung

quinpeung (77.11) Score: +550.15

"Horace Grant is my favorite Bull" said no Bulls fan ever!

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
quinpeung 77.11 3/4/2019 Outperform 5Y $0.52 +566.02% +16.12% +549.91 2 Comments
FoolPep 31.41 10/20/2016 Outperform 3M $0.68 +405.88% +51.03% +354.86 0 Comment
TMFang4apples 79.79 7/1/2020 Underperform NS $6.65 -48.27% +3.98% +52.25 0 Comment
Almostperfect1 83.95 7/16/2020 Underperform 5Y $5.22 -34.10% +0.79% +34.89 0 Comment
luvnpeas 81.73 9/8/2020 Underperform 5Y $4.81 -28.48% -4.06% +24.42 0 Comment
PAGEBOY54 96.14 6/5/2020 6/23/2020 Outperform 5Y $2.83 +21.55% +1.75% +19.80 0 Comment
birdup 26.53 6/18/2020 Outperform 5Y $3.06 +12.42% +4.07% +8.35 1 Comment
ChanceClub 76.89 8/17/2020 Underperform 5Y $3.72 -7.53% -4.42% +3.10 0 Comment
noSPORTSMANSHIP 99.85 8/27/2020 Underperform 3W $3.83 -10.18% -7.32% +2.86 0 Comment
rwenschlag < 20 6/15/2020 Outperform 3Y $3.10 +10.97% +8.37% +2.60 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CYDY.